Array BioPharma Inc. (ARRY) CFO Michael Carruthers sells 1,310 Shares

CFO of Array BioPharma Inc. (ARRY, Financial) Michael Carruthers sells 1,310 shares of ARRY on 03/11/2011 at an average price of $3.11 a share.

Array Biopharma Inc. has a market cap of $167.2 million; its shares were traded at around $2.98 with and P/S ratio of 3.1. Array Biopharma Inc. had an annual average earning growth of 20.9% over the past 10 years.

CFO Recent Trades:

  • Sell: CFO Michael Carruthers sold 1,403 shares of ARRY stock on 02/11/2011 at the average price of 2.91. Michael Carruthers owns at least 88,314 shares after this. The price of the stock has increased by 2.41% since.
  • Sell: CFO Michael Carruthers sold 1,272 shares of ARRY stock on 01/12/2011 at the average price of 3.2. Michael Carruthers owns at least 89,717 shares after this. The price of the stock has decreased by 6.88% since.
  • Sell: CFO Michael Carruthers sold 1,256 shares of ARRY stock on 12/10/2010 at the average price of 3.24. Michael Carruthers owns at least 89,650 shares after this. The price of the stock has decreased by 8.02% since.
  • Sell: CFO Michael Carruthers sold 1,220 shares of ARRY stock on 11/12/2010 at the average price of 3.33. Michael Carruthers owns at least 90,906 shares after this. The price of the stock has decreased by 10.51% since.
  • Sell: CFO Michael Carruthers sold 1,225 shares of ARRY stock on 10/12/2010 at the average price of 3.32. Michael Carruthers owns at least 92,126 shares after this. The price of the stock has decreased by 10.24% since.

Directors and Officers Recent Trades:

  • Sell: VP, General Counsel John R Moore sold 2,959 shares of ARRY stock on 01/11/2011 at the average price of 3.3. John R Moore owns at least 356 shares after this. The price of the stock has decreased by 9.7% since.
  • Sell: VP, General Counsel John R Moore sold 24,039 shares of ARRY stock on 01/06/2011 at the average price of 3.25. John R Moore owns at least 3,315 shares after this. The price of the stock has decreased by 8.31% since.
  • Sell: Director Kyle Lefkoff sold 10,000 shares of ARRY stock on 11/18/2010 at the average price of 3.27. Kyle Lefkoff owns at least 44,585 shares after this. The price of the stock has decreased by 8.87% since.
  • Sell: VP, General Counsel John R Moore sold 20,067 shares of ARRY stock on 10/05/2010 at the average price of 3.29. John R Moore owns at least 27,354 shares after this. The price of the stock has decreased by 9.42% since.


For the complete insider trading history of ARRY, click here.